Migrium 5 mg (Tablet)

Unit Price: ৳ 4.00 (5 x 10: ৳ 200.00)

Strip Price: ৳ 40.00

Medicine Details

Prophylaxis of classic (with aura) or common (without aura) migraine
Symptomatic treatment of vestibular vertigo (due to a diagnosed functional disorder of the vestibular system)
Peripheral Vascular Disease (PVD)
Motion sickness
Refractory epilepsy resistant to conventional antiepileptic therapy

Migraine Prophylaxis: Starting Dose 10 mg at night in patients less than 65 years of age and 5 mg daily in patients older than 65 years
Maintenance Treatment: Dose should be decreased to 5 days treatment at the same daily dose with two successive medicine free days every week
Peripheral Vascular disease: 10 mg twice daily, up to 30 mg per day if required
Vertigo & motion sickness: 10-20 mg daily for adults and 5 mg daily for children (> 40 kg)
Epileptic seizure: 15-20 mg daily in adults and 5 to 10 mg daily for children as an add-on therapy

Galactorrhoea reported in few women on oral contraceptives within the first two months of Migrium treatment
Hepatic enzyme inducers such as Carbamazepine and Phenytoin may interact with Migrium by increasing its metabolism

Hypersensitivity to Flunarizine
Contra-indicated in patients with a history of depressive illness
Contra-indicated in patients with pre-existing symptoms of Parkinson's disease or other extrapyramidal disorders

Drowsiness and/or fatigue
Weight gain and/or increased appetite
Depression (female patients with a history of depressive illness may be particularly at risk)
Extrapyramidal symptoms (bradykinesia, rigidity, akathisia, orofacial dyskinesia, tremor)
Heartburn
Nausea
Gastralgia
Insomnia
Anxiety
Galactorrhoea
Dry mouth
Muscle ache
Skin rash

May lead to drowsiness which is aggravated by the simultaneous intake of alcohol or other central nervous system depressants
Not suited for aborting a migraine attack
Extrapyramidal and depressive symptoms may occur
May reveal Parkinsonism, especially in predisposed patients such as the elderly